From strategy to transaction.
5M Consulting works at the intersection of pharmaceutical commercial strategy, market access, payer reality and provider execution in Saudi Arabia.
The brand. The payer. The claim.
Dr. Walid Al Anani brings more than two decades across pharmaceutical commercial operations, health insurance and consulting. That cross-system experience shapes how 5M reads a product: its commercial ambition, the payer’s decision, and the provider’s ability to execute.
What are we trying to position and grow?
What will be covered, and under what conditions?
What must happen for treatment to proceed?
A specialist perspective, developed over time.
The recurring question in 5M’s body of work is why a clinically relevant product can attract demand and still struggle to reach patients. Early work on reimbursement and denial reasons grew into an integrated view of product performance, launch planning, evidence, payer strategy and practical execution.
The original signature—Mastering Medical Market Monetization Methodologies—remains part of the brand’s heritage. The delivery method is expressed consistently through Measuring Metrics, Masterplanning, Managing, Maximizing and Monitoring.
Explore the methodBring us one product.
What is happening to it in Saudi Arabia—and why? Let’s identify the questions worth investigating.